NCT00946010

Brief Summary

The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,228

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2008

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2008

Completed
1.3 years until next milestone

First Posted

Study publicly available on registry

July 24, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2010

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

January 24, 2011

Status Verified

January 1, 2011

Enrollment Period

2.3 years

First QC Date

April 1, 2008

Last Update Submit

January 20, 2011

Conditions

Keywords

Hepatitis BHepatitis CgenotypeDNA levelRNA levelTaiwan

Outcome Measures

Primary Outcomes (1)

  • genotype and DNA level or RNA level of HBV and HCV virus

    once during Mar. 2008- Jan. 2011

Study Arms (1)

1

Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan

Biological: blood sampling and abdominal sonography

Interventions

10cc blood sampling and abdominal sonography

Also known as: 10cc blood sampling and abdominal sonography
1

Eligibility Criteria

Age23 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.

You may qualify if:

  • Born before 1985/01/01
  • HBV or HCV carriers

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Biospecimen

Retention: SAMPLES WITH DNA

10ml blood was sampled and then serum was be retained.

MeSH Terms

Conditions

Hepatitis BHepatitis C

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitisLiver DiseasesDigestive System DiseasesFlaviviridae InfectionsRNA Virus Infections

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Jin-Chuan Sheu, M.D. P.H.D.

    National Taiwan University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 1, 2008

First Posted

July 24, 2009

Study Start

April 1, 2008

Primary Completion

August 1, 2010

Study Completion

January 1, 2011

Last Updated

January 24, 2011

Record last verified: 2011-01

Locations